Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrointestinal AADC and Levodopa PK in Parkinson's Disease
NCT07793461Phase 4Not yet recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jul 2027
- Primary completion
- Jul 2030
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in Parkinson's disease (PD), sponsored by Beth Israel Deaconess Medical Center. Planned start Jul 2027; status: not yet recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07793461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07793461.